

HY-161356 · 5 mg
MedChemExpress · Cat: HY-161356
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/bpr3p0128.html
Description
BPR3P0128 is an orally active, non-nucleoside RNA-dependent RNA polymerase RdRp inhibitor that has been shown to inhibit the activity of various SARS-CoV-2 variants. The EC50 for SARS-CoV-2 and HCoV-229E are 0.62 ?M and 0.14 ?M. BPR3P0128 demonstrates effective anti-pancoronavirus activity within the submicromolar range. PR3P0128 shows synergistic antiviral activity when combined with Remdesivir HY-104077 .







